Cervicitis by Iontophoresis

CERVICITIS Clinical Trial

Official title:

Effectiveness of Iontophoresis in Managing Uterine Cervicitis

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT05675293
• Other study ID #: IONTOPHORESIS FOR CERVICITIS
• Status: Not yet recruiting
• Phase: Early Phase 1
• Start date: January 15, 2023
• Est. completion date: February 2023

Study information

• Verified date: January 2023
• Source: October 6 University
• Contact: MARIAM HELMY, DEMONSTRATOR
• Phone: 01129985772
• Email: MARIAMHELMYMHR[@]GMAIL.COM
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of the study is to:

Investigate effect of iontophoresis on managing uterine cervicitis.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 40
• Est. completion date: February 2023
• Est. primary completion date: February 2023
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 20 Years to 50 Years

Eligibility

Inclusion Criteria:

1. All patients have vaginal discharge.

2. All patients have irregular vaginal bleeding, especially after sexual intercourse.

3. All patients have dyspareunia.

4. All patients have Lower abdominal pain.

5. Group A: 20 women will receive oral medication (antibiotic zesrosin) and hot water with antiseptic.

6. Group B: 20 women will receive medication by iontophoresis (antibiotic ceftriaxone) and hot water with antiseptic.

Exclusion Criteria:

1. Patients with a history of hypersensitivity or adverse reactions associated with the delivered drug in (ceftriaxone).

2. Patients with prior medical histories of cardiac arrhythmias or hypercoagulability should not receive the procedure near cardiac pacemakers and superficial blood vessels.

3. In the vicinity of embedded wires, stapes, orthopedic implants, and areas of skin with lesions and impaired sensation.

4. It either should not be used or used with extreme caution during pregnancy.

Related Conditions & MeSH terms

• CERVICITIS
• Uterine Cervicitis

Intervention

Device:
• IONTOPHORESIS
The process of increasing the penetration of drugs into the skin by application of an electric current

Drug:
• ORAL ANTIBIOTIC
Oral Antibiotic

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
October 6 University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Difference in change in Urine Analysis and Cervical swab results in both groups	Presence of Pus Cells in Urine Analysis and a Positive Cervical swab results	7 Days difference between pre and post tests